Purpose An increasing consumption of opioids in the general population has been reported in several countries also among pregnant women. Limited information is available regarding the effect of prenatal exposure to analgesic opioids on long-term neurocognitive function in children. The primary aim of the study was to determine the association between prenatal exposure to analgesic opioids and language competence and communication skills at 3 years of age. Methods The Norwegian Mother and Child Cohort Study (MoBa) prospectively included pregnant women during the period from 1999 to 2008. Participants reported medication use at pregnancy weeks 17-18 and 30, and 6 months after birth. Children's language competence and communication skills were reported by mothers on validated scales. Results A total of 45 211 women with 51 679 singleton pregnancies were included. The use of analgesic opioids was reported in 892 pregnancies (1.7%). In adjusted analyses, no association between opioid use and reduced language competence or communication skills was found, OR = 1.04 (95%CI: 0.89-1.22) and OR = 1.10 (95%CI: 0.95-1.27), respectively. Both pain and use of paracetamol were associated with a small reduction in communication skills. No such association was found for language competence. Conclusion The use of analgesic opioids in pregnant women does not seem to affect language development or communication skills in children at 3 years of age.
INTRODUCTION
Data from the general population suggest increasing consumption of prescription opioids in several countries. [1] [2] [3] [4] [5] Also among pregnant women, there is a high prevalence of opioid use. 6, 7 In studies from the USA, 14-28% of pregnant women report opioid use during pregnancy. 6, 8, 9 In Norway, opioids have been reported to be the central nervous system (CNS) acting drugs most frequently prescribed to pregnant women, 10 but with a lower prevalence of use than reported in the USA. Analgesic opioid use is reported in about 3% of all pregnant women in Norway 11 and below 2% during all three trimesters in Sweden. 12, 13 For chronic pain, the American Pain Society Guidelines recommend no or minimal use of prescribed opioids in pregnancy, if possible. 14 The Norwegian Medical Association has recommended that opioids be used sporadically for severe pain during the first and second trimesters but warned about treatment close to term because of potential perinatal complications, the most studied being neonatal abstinence syndrome. 15 Limited information is available regarding the effect of prenatal exposure to analgesic opioids on long-term neurocognitive function in children.
Language development plays a fundamental role in cognition, social development, and learning. Early language deficits may impair long-term social adaptation, cognitive development, and academic achievement and are associated with psychiatric disorders in young adults. [16] [17] [18] [19] Developmental delay in the language domain is also often found to be associated with delay in other domains. 16, 20 Thus, a potential effect of drug intake during pregnancy on language and communication development in the offspring would be an important safety issue. There are some reports on cognitive development after use of illicit opioids or medication assisted maintenance therapy during pregnancy, but the results are conflicting. 21, 22 No population-based estimates are available regarding the risk of delayed language development children born to mothers using opioid analgesics during pregnancy.
The aim of the present study was to assess the effect of exposure to analgesic opioids during pregnancy on language competence and communication skills in 3-year-old children.
MATERIAL AND METHOD

The MoBa cohort
The Norwegian Mother and Child Cohort Study (MoBa) is a prospective population-based pregnancy cohort run by the Norwegian Institute of Public Health. 23, 24 During the period from 1999 to 2008, pregnant women in Norway received a postal invitation to participate in MoBa prior to the first ultrasound scan at weeks 17-18. The women consented to participation in 40.6% of the pregnancies. Data collection is based on detailed self-administered questionnaires, both during pregnancy and after birth on questions regarding in utero exposures that may increase the likelihood of delayed neurodevelopment such as alcohol consumption, smoking, illicit drug use, and use of prescription medication like opioids, selective serotonin reuptake inhibitors (SSRI), and benzodiazepines. 25, 26 Participants answered three questionnaires during pregnancy as well as 6 and 18 months and 3, 5, 7, and 8 years after birth. Follow-up of children in MoBa is still ongoing. The cohort now includes 114 500 children, 95 200 mothers, and 75 200 fathers. Some of the information in MoBa is obtained by linkage to the Medical Birth Registry of Norway, which is a nationwide registry based on mandatory notification of all births or late abortions in Norway. 27 
Study population
The present study is based on data from pregnant women and their offspring having reached the age of 3 years (MoBa data file version 7). The age three questionnaire was returned for 58 410 children. Children from pregnancies with multiple fetuses (n = 1748) and children with malformations and/or chromosomal abnormalities (n = 1555) were excluded, as were pregnancies where the mother did not answer all three questionnaires on drug use during pregnancy (n = 3069). Pregnancies with missing data on language competence and/or communication skills (n = 359) were also excluded, resulting in 51 679 pregnancies in 45 211 women.
Opioid use
Opioids were defined as all analgesics classified in ATC-group N02A on the basis of the Anatomic Therapeutic Chemical classification system as of 2013. 28 Opioid containing cough medications (R05DA01 and R05DA04) were registered for sensitivity analyses. Mothers were asked to report on medication use at pregnancy weeks 17-18 and 30, and 6 months after birth, 25 covering the period from 6 months before pregnancy to weeks 17-18, the period from weeks 19 to 29, and the period from week 30 to birth. Complete questionnaires are available from the Norwegian Institute of Public Health (http://www.fhi. no/enmoba).
Mothers were defined as analgesic opioid users if they had reported use of any analgesic opioid on at least one of the three questionnaires by naming a drug as well as ticking a box indicating that they had used the drug during pregnancy. To try to capture the extent of exposure, we classified use as none, during one period only, or during two or all three pregnancy periods. In addition, binary exposure in each pregnancy period was registered.
Language competence
Language competence at 3 years of age was evaluated by a validated language grammar rating scale. 29 The mother classified her child's language competence according to six different categories:
(1) not yet talking; (2) talking, but unintelligible; (3) talking in one-word utterances such as "milk" or "down"; (4) talking in two-word to three-word phrases, such as "me got ball" or "give doll"; (5) talking in fairly complete sentences, such as "I got a doll" or "Can I go outside?"; and (6) talking in long and completed sentences, such as "When I went to the park, I went on the swings" or "I saw a man standing on the corner."
Categories 1-4 were combined in the analyses because of small numbers. If the mother had marked several categories, the child was classified in the most advanced language category. The validity of the language grammar rating scale has been evaluated by Roth et al. 30 
Communication skills
Communication skills were assessed by six items from the Ages and Stages Questionnaire (ASQ), which is considered to be an effective screening tool for detecting developmental impairments or disturbances. 31 Mothers rated the child's ability to master different skills (described in Table S1 ) using the categories yes, sometimes,
or not yet, scored 10, 5, and 0, respectively, as suggested by Squires. 32 Mean scores were estimated if the mother had filled in at least three of the six items constituting the scale and, thereafter, grouped in three ordinal categories for statistical analysis. In addition, a z-score was calculated with a cutoff of 1.5 for supplementary analyses. 32 
Potential confounding factors
A large number of factors may be associated with opioid use during pregnancy as well as with language competence and communication skills in the offspring. Maternal and paternal education level, marital status and maternal work situation during pregnancy, information on whether the pregnancy was planned or not, the use of folic acid supplements in early pregnancy, pre-pregnancy body mass index (BMI; kg/m 2 ), and chronic diseases were retrieved from the first pregnancy questionnaire. Reports on other drug use, smoking, and alcohol use as well as pain were retrieved from all three questionnaires. Information regarding maternal and paternal age and parity was retrieved from the Medical Birth Registry of Norway.
The three questionnaires posed questions on pain slightly differently. All categories of pain reported were therefore merged into one binary pain variable (yes/no). Maternal chronic disease was defined if a pregnant woman reported asthma, diabetes, hypertension, arthritis, lupus, Crohn's disease, epilepsy, multiple sclerosis, or cancer in the first questionnaire.
Associations between potential confounding factors and opioid use during pregnancy (exposure) and language and communication skills (separate outcomes) were estimated. All factors shown to be independent explanatory variables for outcome as well as explanatory variables for exposure were included in the final model.
Statistics
Ordinal logistic regression (proportional odds model) 33 was applied to estimate the association between prenatal analgesic opioid exposure and language competence or communication skills, respectively. Both outcome variables were ordered in three categories, with scores ranging from 1 to 3. The outcome can then be categorized in two ways: development category 1 vs. 2-3 or 1-2 vs. 3. The interpretation of the odds ratio (OR) is the change in the odds of being in a lower development category per unit increase in the independent variable, regardless of how the outcome has been dichotomised.
The assumption of proportionality of odds for the ordinal models was checked by an approximate likelihood ratio test. Additional sensitivity analyses of the same outcomes in three to five categories using multinomial logistic regression and binary logistic regression with different two category cutoffs of the outcome variables were also performed. To study if there was a sensitive period during pregnancy, we also modeled the effect of binary exposure during three time intervals. Separate analyses of opioid containing cough medications compared with the reference group with no opioid use were also performed.
For communication skills, a supplementary analysis using the z-score with a cutoff of 1.5 SD below the mean was conducted.
Unadjusted as well as adjusted analyses, including all potential confounding factors (as mentioned earlier), were performed, and 95% confidence intervals (CIs) for the OR were calculated. Standard errors were estimated using the clustered sandwich estimator to handle multiple pregnancies in the same woman. Statistical analyses were conducted using STATA 14.
RESULTS
Pain
In 47 058 (91.1%) pregnancies, the woman reported pain on at least one questionnaire. Back pain or pelvic pain was reported in 44 877 pregnancies (86.8%), and in 20 249 pregnancies (39.4%), the woman reported that pelvic pain made her wake up at night. Headache or other pain was reported in 29 220 pregnancies (56.5%).
Opioid use
The use of analgesic opioids was reported in 892 of the 51 679 pregnancies (1.7%). Opioid use during one period only was reported in 720 pregnancies (1.4%), whereas drug use in at least two periods was reported in 172 (0.3%).
The dominating substance was codeine in combination with paracetamol, reported in 799 (89.6%) of the 892 pregnancies. The use of a strong opioid was reported in 117 (13.1%) of exposed pregnancies. In 653 pregnancies, the use of opioid containing cough medication was reported. Table 1 shows maternal use of analgesic opioids during pregnancy according to parental characteristics. The use of opioids was less common with increasing maternal education and age as well as in working mothers, whereas the proportion of users increased with increasing parity and BMI. The proportion of opioid users was also higher when the mother reported pain, chronic disease, smoking, use of triptans, benzodiazepines, SSRIs, and illegal drugs. Maternal work situation, parity, paternal education, maternal smoking, maternal BMI, and maternal use of benzodiazepine or SSRI during pregnancy were independent explanatory variables for both outcome and exposure. Table 2 shows the number and proportion of children in the different language competence categories reported by the mothers in the 3 years questionnaire by maternal use of analgesic opioids during pregnancy. Only very small differences were observed between children prenatally exposed to opioids during either one or two to three periods and children prenatally not exposed. Table 3 shows estimated ORs of lower language competence when exposed to analgesic opioids in utero. In unadjusted analyses, there was a trend towards a small detrimental effect of prenatal exposure to opioids, but there was no effect of opioid use on language competence in adjusted analyses. The OR of language competence in a lower category was 1.04 (95%CI: 0.89-1.22) with the use of analgesic opioids whether or not pain was included in the model.
Language competence
Unadjusted analyses show small increases in the odds of being in a lower language development category in children exposed to paracetamol or maternal pain, respectively. In adjusted analyses, including all potential confounding factors, however, there was no effect of number of periods with reported use of paracetamol or pain during pregnancy.
Sensitivity analyses using binary logistic regression models with different cutoffs as well as multinomial logistic regression models with different numbers of categories of language development supported the results from the ordinal models. So did the model assessing exposure during different periods. There was no association between the use of opioid containing cough medication and language development, OR = 1.00 (95%CI: 0.82-1.22).
Communication skills
The number and proportion of children in the different categories of communication skills are shown in Table 2 . Small differences were observed between children prenatally exposed to analgesic opioids and children not exposed.
There were small effects of prenatal exposure to opioids, paracetamol, and maternal pain in unadjusted analyses (Table 4) . However, no effect of analgesic opioid use on communication skills was found in adjusted analyses; the estimated OR of being in a lower category being 1.10 (95%CI: 0.95-1.27). Categorizing opioid use into one period or two or three periods gave OR = 1.10 (95%CI: 0.94-1.28) and No association between the use of cough medication and communication skills was found, OR = 0.96 (95% CI: 0.81-1.13).
DISCUSSION
In this large prospective study, we have assessed the association between prenatal exposure to analgesic opioids and language competence or communication skills at 3 years of age.
An increase in opioid use during the last two decades has been documented in several populations. 1, 2, 4, 5 This trend has been accompanied by a rise in abuse of these agents. 34 Studies from the US pregnant population suggest that the epidemic use of prescribed opioids in the general population extends to use during pregnancy. 6, 8, 35 Even if no increasing trend in opioid use is evident in Norway or other Scandinavian countries, 10, 36 neither in the general population (www.norpd.no) 2 nor in the population of pregnant women, 11 it is highly important to gain knowledge on potential harmful effects to the offspring.
There is a growing body of evidence that opioids may be associated with specific birth defects, and codeine is potentially an important contributor. 7, 37 In a review of the literature, no association between opioid exposure and head circumference or birth length was found, 7 but results regarding a potential effect on birth weight and preterm birth have been inconclusive.
To our knowledge, no studies have been performed with respect to neurocognitive effects of prescribed analgesic opioids. Some studies have found children exposed to opioid maintenance treatment to have reduced cognitive function compared with unexposed. 22 The presence of several other risk factors may have confounded the association, and a firm conclusion on causality cannot be drawn.
In the present study, there was no association between analgesic opioid use during pregnancy and language competence or communication skills in 3-year-old children, respectively. Because both exposure and outcome are rare events, a large sample is required to obtain sufficient power to detect associations. A major strength of this study is the large number of pregnancies leading to relatively precise estimates. The upper limits of the 95% CIs seem to preclude any large effect of prenatal exposure to analgesic opioids. As MoBa participants responded to detailed questions regarding drug use as well as a large number of other health-related and sociodemographic factors, it was possible to control for several important potential confounders. The prospective design to some extent reduces the risk of recall bias as the women reported on drug use before assessing the outcomes of interest.
Whereas there seems to be no relevant association between prenatal exposure to opioids and neurocognitive development at 3 years, there was an association between prenatal exposure to paracetamol and communication skills, the odds of being in a lower development category increasing with number of pregnancy periods with reported use of paracetamol. Residual confounding cannot be excluded, but this finding is supported by an earlier MoBa study, which showed a weak association between long-term use of paracetamol and communication skills both in the cohort and in sibling-adjusted analyses.
38
A large proportion of pregnant women reports pain during pregnancy. Maternal pain in itself might affect neurodevelopment, but to our knowledge, such effects have not been studied. The results of this study did not indicate any substantial effect of maternal pain on the child's language competence. However, there was a small association with communication skills. Unfortunately, the questions on pain during pregnancy are not identical in the different MoBa questionnaires, and refined and consistent classification of duration and type of pain was not possible. A majority reported pregnancyrelated pain, such as back pain or pelvic girdle pain.
In Norway, the weak opioid codeine is the dominating prescribed opioid analgesic, and the products on the market contain 30 mg per tablet. 9 As codeine was reported in approximately 90% of the 892 exposed pregnancies, our results are most representative for this substance. The prevalence of opioid use in MoBa is rather small (1.7%), and we chose to classify all analgesic opioids together. The value of studying subgroups of opioids as, for example, oxycodone, would be very limited. A separate exploratory analysis of strong opioids led to approximately the same results as for all opioids combined, but the number of women was too low for appropriate adjustment for confounding, and no firm conclusion can be drawn. Cough medications (R05D) were not included in the main analyses as the dose is low and duration of use expected to be very short. In light of our findings on analgesic opioids, it is no surprise that supplementary analyses of use of opioid containing cough medications versus no opioid use revealed no association with neurocognitive development.
We do not have information on dosage or duration of use of opioids. A mother who has reported the use of opioids during a period may have used the drug once only or possibly every day, and any conclusions with regard to duration should be dealt with cautiously. However, mothers reporting the use during two or more periods are more likely to have consumed a higher total dose. This assumption is also supported by the fact that a larger proportion of women using opioids in more periods also use benzodiazepines.
11
In a nation-wide registry study, 2.9% of pregnant women filled at least one prescription of opioid analgesics. 11 The discrepancy between that estimate and the prevalence of opioid use of 1.7% reported in the present study may partly be explained by selection bias. 39 Only women agreeing to participate in MoBa have been included in the study, and it has been shown that MoBa participants have a healthier lifestyle than the total pregnant population in Norway. They may also be more cautious with regard to drug use during pregnancy. However, a comparison of MoBa participants and all women giving birth in Norway suggests that estimates of exposure-outcome associations are unbiased. 39 In addition to the effect of self-selection, there is the possibility of misclassification of drug consumption. Previous studies have demonstrated a lower proportion of self-reported drug use in MoBa compared with data from the NorPD in the same sample. 40 In that study, 2.1% filled opioid prescriptions during pregnancy, whereas 1.6% self-reported opioid use. It is not surprising that the prevalence estimate is lower using self-reports than in the prescription database as dispensed drugs need not be consumed. However, there is also a risk that mothers underreport their use of drugs in the questionnaires. Underreporting of exposure is, on the other hand, assumed to have little effect on the estimated ORs. It has been shown that when the prevalence of exposure is low, high specificity, that is, classification of true unexposed as unexposed, is highly important, whereas sensitivity is less important. 41 Parental self-report is generally considered a valid measure of early expressive vocabulary, especially for severe language delay, and a validation against clinical assessment has been described for this instrument in our cohort. 30 The ASQ at the age of 3 years has also been validated. 32 The distribution of ASQ3 scores originally comprises 21 categories and could, in principle, have been treated as a continuous variable. However, the distribution was heavily skewed, and ordinal logistic regression with three categories was therefore applied. Sensitivity analyses with a larger number of categories led to very small numbers in the lowest category and violation of the assumption of proportionality. Using a z-score as recommended for screening led to the same conclusion because the recommended cutoff corresponds exactly to the lowest of the three ASQ3 score categories (≤7.5). In adjusted analyses of language competence use of four categories instead of three led to the same estimates, but with slightly less certain fulfillment of the proportionality assumption. Language competence was registered in six ordinal categories, but the number of children in the three lowest categories was small, and we decided to restrict the primary analysis to three ordinal categories. Supplementary analyses with the outcome ordered in four categories did not affect the results.
Conclusion
No association between maternal analgesic opioid use during pregnancy and language competence or communication skills in 3-year-old children was detected. Our findings are based on a cohort of pregnant women where a small proportion report use of analgesic opioids and primarily codeine in short periods and probably small doses. Therefore, the results are not necessarily applicable to strong opioids, large doses, or long duration during pregnancy. Even if any strong effect on language competence or communication skills seems unlikely, healthcare providers should carefully consider both the underlying disease of a pregnant women and potential harm to the developing fetus before prescribing an opioid. Future research, especially on heavy use of prescribed opioids and neurodevelopment of the child, is necessary.
